Sarentis Therapeutics
New York, US
Biotech
Founders & leadership
DB
Denise BarbutExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements$750KraisedJul 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.